Published in Psychosom Med on February 13, 2001
Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol (2005) 2.19
Sleep loss activates cellular inflammatory signaling. Biol Psychiatry (2008) 2.11
Cytokine, sickness behavior, and depression. Neurol Clin (2006) 1.58
Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am (2009) 1.56
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36
Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun (2008) 1.35
Interleukin 18 in the CNS. J Neuroinflammation (2010) 1.26
Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol (2011) 1.26
Predictors of inflammation in U.S. children aged 3-16 years. Am J Prev Med (2010) 1.21
Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev (2008) 1.16
Diseases of poverty and lifestyle, well-being and human development. Mens Sana Monogr (2008) 1.10
Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities [ARIC] study). Am J Cardiol (2010) 1.03
Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med (2008) 1.01
Family poverty is associated with cytomegalovirus antibody titers in U.S. children. Health Psychol (2011) 0.95
Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med (2010) 0.95
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav Immun (2011) 0.93
Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med (2003) 0.92
Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. Brain Behav Immun (2010) 0.92
Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics. Biodemography Soc Biol (2009) 0.90
Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun (2008) 0.87
Depression, stress, and the heart. Heart (2002) 0.84
Distinct trajectories of fatigue in chronic heart failure and their association with prognosis. Eur J Heart Fail (2010) 0.80
Depression: a symptom of coronary artery disease or a pathogenetic factor? Psychosom Med (2001) 0.79
Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl Psychiatry (2016) 0.78
Depression and coronary artery disease: time to move from observation to trials. CMAJ (2003) 0.77
Clinical and socio-demographic predictors of postoperative vital exhaustion in patients after cardiac surgery. Heart Lung (2013) 0.75
Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study. Eur J Cardiovasc Nurs (2013) 0.75
An investigation on the effect of strength and endurance training on depression, anxiety, and C-reactive protein's inflammatory biomarker changes. J Res Med Sci (2012) 0.75
Depression and the heart. Indian Heart J (2012) 0.75
Vital exhaustion increases the risk of ischemic stroke in women but not in men: results from the Copenhagen City Heart Study. J Psychosom Res (2009) 0.75
Psychological Stress, Inflammation, and Coronary Heart Disease. Curr Cardiol Rep (2017) 0.75
Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J (1982) 6.79
Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery. Am Heart J (1989) 2.35
The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med (1978) 2.20
Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1988) 1.53
Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med (1994) 1.52
Prediction of restenosis after coronary balloon angioplasty. Results of PICTURE (Post-IntraCoronary Treatment Ultrasound Result Evaluation), a prospective multicenter intracoronary ultrasound imaging study. Circulation (1997) 1.51
Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol (1976) 1.41
Value of the electrocardiogram in diagnosing the number of severely narrowed coronary arteries in rest angina pectoris. Am J Cardiol (1993) 1.32
Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. J Am Coll Cardiol (1999) 1.27
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol (1988) 1.19
Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci (2004) 1.19
Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am J Cardiol (1982) 1.16
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway. Am J Cardiol (1980) 1.12
Angiographic assessment of prospectively determined non-invasive reperfusion indices in acute myocardial infarction. Heart (2000) 1.12
Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab (2005) 1.09
Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am J Cardiol (1977) 1.09
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation (1986) 1.08
[Rehabilitation of heart patients during admission and following discharge from the hospital: figures and trends]. Ned Tijdschr Geneeskd (1990) 1.08
Predictors of return to former leisure and social activities in MI patients. J Psychosom Res (1991) 1.04
Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation (1995) 1.04
Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol (2000) 1.04
Differential diagnosis of tachycardia with narrow QRS complex (shorter than 0.12 second). Am J Cardiol (1984) 1.03
Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am J Pathol (1994) 1.02
Initiation and termination of ventricular tachycardia by supraventricular stimuli. Incidence and electrophysiologic determinants as observed during programmed stimulation of the heart. Am J Cardiol (1980) 1.02
Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction. Am Heart J (1999) 0.99
Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. J Psychosom Res (2000) 0.96
Pacemaker related tachycardias. Pacing Clin Electrophysiol (1982) 0.96
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study. J Am Coll Cardiol (1999) 0.94
Symptomatic and asymptomatic rotavirus infections in hospitalized children. Acta Paediatr Scand (1983) 0.94
Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J (1977) 0.92
Reciprocal tachycardias using accessory pathways with long conduction times. Am J Cardiol (1979) 0.91
Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model. Intervirology (1999) 0.90
Physicochemical parameters and subunit composition of yeast phosphofructokinase. Eur J Biochem (1977) 0.89
Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology (1998) 0.89
Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1995) 0.89
Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation (1997) 0.87
Expression of TGF-beta and PDGF-AA antigens and corresponding mRNAs in cytomegalovirus-infected rat kidney allografts. Transplant Proc (2003) 0.87
Value of the ST-T segment in lead V4R in inferior wall acute myocardial infarction to predict the site of coronary arterial occlusion. Am J Cardiol (1988) 0.86
Prostate-specific antigen forms complexes with human alpha 2-macroglobulin and binds to the alpha 2-macroglobulin receptor/LDL receptor-related protein. J Urol (1998) 0.86
Limited proteolysis of yeast phosphofructokinase. Sequence locations of cleavage sites created by the actions of different proteinases. Eur J Biochem (1993) 0.86
Termination of tachycardias by interrupting blood flow to the arrhythmogenic area. Am J Cardiol (1988) 0.85
Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats. Am J Pathol (2000) 0.83
Medical treatment of ventricular tachycardia: considerations in the selection of patients for surgical treatment. Am J Cardiol (1982) 0.83
"Sawfish" systolic narrowing of the left anterior descending coronary artery: an angiographic sign of hypertrophic cardiomyopathy. Circulation (1982) 0.83
Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat. Transplantation (1997) 0.83
Electrical management of arrhythmias with emphasis on the tachycardias. Am J Cardiol (1978) 0.82
Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation. Br Heart J (1981) 0.82
CMV-induced class II antigen expression in various rat organs. Transpl Int (1994) 0.82
Cytomegalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral prophylaxis. Transplant Proc (2001) 0.82
Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats. Transplant Proc (1994) 0.81
Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris. Am J Cardiol (1991) 0.81
The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res (1996) 0.81
Indications for use of intracardiac electrophysiologic studies for the diagnosis of site of origin and mechanism of tachycardias. Circulation (1987) 0.80
Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection. Transplantation (1999) 0.80
Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. Am J Cardiol (1980) 0.80
Test characteristics of acridine orange, Gram, and May-Grünwald-Giemsa stains for enumeration of intracellular organisms in bronchoalveolar lavage fluid. J Clin Microbiol (1999) 0.80
N-acetylcysteine prevents neointima formation in experimental venous bypass grafts. Br J Surg (2009) 0.80
Age- and sex-related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats. Clin Exp Immunol (1997) 0.80
Removal of thrombus from aortocoronary bypass grafts and coronary arteries using the 6Fr Hydrolyser. Am J Cardiol (1997) 0.80
Rotavirus infections in high-risk neonates. J Hosp Infect (1984) 0.79
CMV increases inflammation and accelerates chronic rejection in rat kidney allografts. Transplant Proc (1997) 0.79
Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo. Eur J Clin Microbiol Infect Dis (1993) 0.79
Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am J Cardiol (1982) 0.79
Guillain-Barré syndrome in mother and newborn child. Lancet (1997) 0.79
Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients. J Neuroimmunol (2003) 0.79
Thallium-201 exercise scintigraphy and left bundle branch block. Am J Cardiol (1985) 0.78
Clinical presentation and prognosis of left main coronary artery disease in the 1980s. Eur Heart J (1991) 0.78
Ribose-5-phosphate isomerase from Saccharomyces cerevisiae: purification and molecular analysis of the enzyme. Bioseparation (1998) 0.78
Purification and characterization of an adenotin-like adenosine binding protein from human platelets. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.78
Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty. Am J Cardiol (1996) 0.78
XANES-EXAFS analysis of se solid-phase reaction products formed upon contacting Se(IV) with FeS2 and FeS. Environ Sci Technol (2008) 0.77
Interaction of enzymes involved in triosephosphate metabolism. Comparison of yeast and rabbit muscle cytoplasmic systems. Eur J Biochem (1986) 0.77
A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment. Exp Neurol (2013) 0.77
A versatile pacemaker system for termination of tachycardias. Am J Cardiol (1983) 0.77
Cytomegalovirus-induced class II expression in rat kidney. Transplant Proc (1994) 0.77
Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage? Am Heart J (1988) 0.77
Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: comparison of infusion, single-bolus, and split-bolus administration. J Thromb Thrombolysis (1999) 0.76
Lipid peroxidation-associated oxidative stress during percutaneous transluminal coronary angioplasty in humans. Free Radic Biol Med (1997) 0.76
A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites. Am J Cardiol (1993) 0.76
Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis. J Immunol (1995) 0.76
Unstable angina: are we able to recognize high-risk patients? Chest (1997) 0.76
Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts. Transpl Int (1996) 0.76
Cytomegalovirus infection enhances connective tissue growth factor mRNA expression in a rat model of chronic renal allograft rejection. Transplant Proc (2001) 0.76
Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial. Am Heart J (1999) 0.75
Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts. Transplant Proc (1995) 0.75
Cardiac rehabilitation and the changing cardiac rehabilitation directions in Hoensbroeck rehabilitation centre. Neth Heart J (2002) 0.75
CMV causes bile duct destruction and arterial lesions in rat liver allografts. Transplant Proc (1997) 0.75
CMV accelerates tubular apoptosis in a model of chronic renal allograft rejection. Transplant Proc (2001) 0.75
CMV increases collagen synthesis in chronic rejection in rat renal allograft. Transplant Proc (1999) 0.75
Quantification of the interaction of Tc with dissolved boom clay humic substances. Environ Sci Technol (2003) 0.75
Clinical experience with implantable devices for control of tachyarrhythmias. Pacing Clin Electrophysiol (1984) 0.75
Evidence for the interaction of technetium colloids with humic substances by X-ray absorption spectroscopy. Environ Sci Technol (2004) 0.75
Prognostic value of Q waves, R/S ratio, loss of R wave voltage, ST-T segment abnormalities, electrical axis, low voltage and notching: correlation of electrocardiogram and left ventriculogram. J Am Coll Cardiol (1984) 0.75
CMV increases TNF-alpha expression in a rat kidney model of chronic rejection. Transplant Proc (2003) 0.75
Value of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction. Cathet Cardiovasc Diagn (1987) 0.75
Detection of nonspecific cytomegalovirus antigen in peripheral blood mononuclear cells after coronary bypass surgery. Eur J Clin Microbiol Infect Dis (2001) 0.75
Electrophysiological studies in patients with the Wolf-Parkinson-White syndrome. Herz (1979) 0.75